← ACCENDRA HEALTH INC/VA/
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $9.7b |
$9.3b
-4.17%
|
$9.8b
+5.59%
|
$9.2b
-6.38%
|
$8.5b
-7.93%
|
$9.8b
+15.39%
|
$10.0b
+1.74%
|
$10.3b
+3.80%
|
$10.7b
+3.55%
|
$2.8b
-74.19%
|
$2.7b
-1.67%
|
|
| Other Cost of Operating Revenue | — | — | — | — | — | — | — | — | — | $22.6m | — | |
| Cost of Goods and Services Sold | $8.5b |
$8.1b
-4.57%
|
$8.5b
+3.99%
|
$8.1b
-4.60%
|
$7.2b
-10.93%
|
$8.3b
+14.90%
|
$8.1b
-1.73%
|
$8.2b
+0.98%
|
$8.5b
+3.32%
|
$1.5b
-82.64%
|
$1.5b
-0.33%
|
|
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | — | — | — | — | — | — | — | — | — | $1.3b |
$1.5b
+10.92%
|
|
| Gross Profit | $1.2b |
$1.2b
-1.30%
|
$1.4b
+16.65%
|
$1.1b
-17.45%
|
$1.3b
+13.50%
|
$1.5b
+18.14%
|
$1.8b
+20.69%
|
$2.1b
+16.36%
|
$2.2b
+4.42%
|
$1.3b
-41.90%
|
$1.2b
-3.20%
|
|
| Research and Development Expense | — | — | — | — | — | — | — | $13.2m | $13.0m | — | — | |
| Selling, General and Administrative Expense | $970.4m | $1.0b | $1.3b | $1.0b | $1.0b | $1.1b | $1.6b | $1.8b | $1.9b | $1.1b | $1.1b | |
| Amortization of Intangible Assets | $10.0m | $16.4m | $36.5m | $44.0m | $41.5m | $39.8m | $78.8m | $83.5m | $64.9m | $74.0m | — | |
| Restructuring and Related Cost, Incurred Cost | $11.9m | $26.1m | $6.7m | — | $10.6m | $11.2m | — | — | — | — | — | |
| Operating Costs and Expenses | — | — | — | — | — | — | — | $2.4b | $2.9b | $2.7b | — | |
| Operating Income (Loss) | $199.6m |
$89.3m
-55.28%
|
($392.2m)
-539.41%
|
$73.2m
+118.65%
|
$204.1m
+179.04%
|
$368.5m
+80.52%
|
$142.9m
-61.21%
|
$104.5m
-26.87%
|
($207.8m)
-298.81%
|
$27.5m
+113.22%
|
$187.7m
+583.43%
|
|
| Other Operating Income (Expense), Net | $7.4m | ($4.9m) | $4.4m | ($2.2m) | $2.4m | $6.2m | $5.3m | ($6.9m) | ($13.3m) | $27.5m | $187.7m | |
| Other Nonoperating Income (Expense) | — | — | — | ($3.8m) | $10.8m | $3.2m | $3.1m | $4.8m | $4.7m | $3.9m | — | |
| Interest Expense (non-operating) | $27.1m | $31.8m | $77.0m | $98.1m | $83.4m | $48.1m | $128.9m | $157.9m | $143.8m | $107.2m | $115.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $150.9m | $49.9m | ($420.0m) | ($33.0m) | $80.6m | $231.4m | ($17.6m) | ($65.4m) | ($383.5m) | ($104.1m) | ($112.8m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $28.7m | $109.9m | $276.8m | $10.9m | ($54.7m) | ($357.4m) | ($102.0m) | ($112.8m) | |
| Current Income Tax Expense (Benefit) | $59.5m | $34.7m | $2.8m | $11.3m | $6.3m | $84.9m | $14.9m | $10.3m | $31.4m | $18.6m | ($7.5m) | |
| Income Tax Expense (Benefit) | $63.8m | ($15.3m) | ($32.2m) | ($6.1m) | $21.8m | $55.2m | ($11.5m) | ($13.4m) | $5.3m | $729k | ($7.5m) | |
| Net Income (Loss) Attributable to Parent | $108.8m |
$72.8m
-33.09%
|
($437.0m)
-700.35%
|
($62.4m)
+85.73%
|
$29.9m
+147.89%
|
$221.6m
+641.82%
|
$22.4m
-89.90%
|
($41.3m)
-284.47%
|
($362.7m)
-778.15%
|
($1.1b)
-203.47%
|
($1.1b)
+1.68%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $107.6m |
$71.7m
-33.36%
|
($437.0m)
-709.22%
|
($1)
+100.00%
|
$0
+145.63%
|
$3
+525.53%
|
$0
-90.14%
|
($1)
-286.21%
|
($5)
-775.93%
|
($14)
-202.54%
|
($1.1b)
-7562040431.10%
|
|
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | $297k | $58k | $0 | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $1.76 | $1.03 | $0.86 | ($1.03) | $0.47 | $3.05 | $0.30 | ($0.54) | ($4.73) | ($14.31) | ($14.07) | |
| Earnings Per Share, Diluted | $1.76 | $1.20 | ($7.28) | ($1.03) | $0.47 | $2.94 | $0.29 | ($0.54) | ($4.73) | ($14.31) | ($14.07) | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | ($0) | $1 | $3 | $0 | ($1) | ($5) | ($1) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | ($0) | $1 | $3 | $0 | ($1) | ($5) | ($1) | — | |
| Common Stock, Dividends, Per Share, Declared | $1.02 | $0.00 | $0.00 | $0.01 | $0.01 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 61.1m | 60.0m | — | — | 63.4m | 72.7m | 74.5m | 75.8m | 76.7m | 76.9m | 76.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 61.1m | 60.0m | — | — | 63.5m | 75.5m | 76.2m | 75.8m | 76.7m | 76.9m | 76.7m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | — | $17.3m | $45.3m | $15.7m | — | — | — | $17.5m | $22.0m | $22.0m | — | |
| Capitalized Computer Software, Amortization | $12.9m | $10.7m | $12.8m | $9.3m | $10.2m | $10.3m | $14.0m | $16.1m | $17.0m | — | — | |
| Goodwill, Impairment Loss | $0 | — | $423.1m | — | $0 | — | — | $0 | $307.1m | $0 | $0 | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | ($22.6m) | $88.1m | $221.6m | $22.4m | $8.9m | $350.7m | ($102.7m) | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $8.9m | $350.7m | ($102.7m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $8.9m | $350.7m | ($998.0m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | ($39.8m) | ($58.2m) | $0 | $0 | $8.9m | $350.7m | ($998.0m) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.